National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

被引:286
作者
Olfson, Mark [1 ]
Blanco, Carlos [1 ]
Liu, Shang-Min [1 ]
Wang, Shuai [1 ]
Correll, Christoph U. [2 ,3 ]
机构
[1] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10027 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] N Shore Long Isl Jewish Hlth Syst, Zucker Hillside Hosp, Glen Oaks, NY USA
基金
美国医疗保健研究与质量局;
关键词
DISRUPTIVE BEHAVIOR DISORDERS; MAJOR DEPRESSIVE DISORDER; BIPOLAR DISORDER; 2ND-GENERATION ANTIPSYCHOTICS; PSYCHIATRIC MEDICATIONS; ATYPICAL ANTIPSYCHOTICS; AMERICANS ATTITUDES; HOSPITAL DISCHARGE; UNITED-STATES; PRIMARY-CARE;
D O I
10.1001/archgenpsychiatry.2012.647
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Although antipsychotic treatment has recently increased, little is known about how this development has differentially affected the office-based care of adults and young people in the United States. Objective: To compare national trends and patterns in antipsychotic treatment of adults and youths in office-based medical practice. Design: Trends between 1993 and 2009 in visits with antipsychotics for children (0-13 years), adolescents (14-20 years), and adults (>= 21 years) are described on a per population basis and as a proportion of total medical office visits. Background and clinical characteristics of recent (2005-2009) antipsychotic visits are also compared by patient age. Setting: Outpatient visits to physicians in office-based practice. Participants: Visits from the 1993-2009 National Ambulatory Medical Care Surveys (N=484 889). Main Outcome Measures: Visits with a prescription of antipsychotic medications. Results: Between 1993-1998 and 2005-2009, visits with a prescription of antipsychotic medications per 100 persons increased from 0.24 to 1.83 for children, 0.78 to 3.76 for adolescents, and 3.25 to 6.18 for adults. The proportion of total visits that included a prescription of antipsychotics increased during this period from 0.16% to 1.07% for youths and from 0.88% to 1.73% for adults. From 2005 to 2009, disruptive behavior disorders were the most common diagnoses in child and adolescent antipsychotic visits, accounting for 63.0% and 33.7%, respectively, while depression (21.2%) and bipolar disorder (20.2%) were the 2 most common diagnoses in adult antipsychotic visits. Psychiatrists provided a larger proportion of the antipsychotic visits for children (67.7%) and adolescents (71.6%) than to adults (50.3%) (P<.001). From 2005 to 2009, antipsychotics were included in 28.8% of adult visits and 31.1% of youth visits to psychiatrists. Conclusions: On a population basis, adults make considerably more medical visits with a prescription of antipsychotics than do adolescents or children. Yet antipsychotic treatment has increased especially rapidly among young people, and recently antipsychotics have been prescribed in approximately the same proportion of youth and adult visits to psychiatrists.
引用
收藏
页码:1247 / 1256
页数:10
相关论文
共 77 条
  • [61] Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness
    Pescosolido, Bernice A.
    Perry, Brea L.
    Martin, Jack K.
    McLeod, Jane D.
    Jensen, Peter S.
    [J]. PSYCHIATRIC SERVICES, 2007, 58 (05) : 613 - 618
  • [62] Pharmacotherapy of bipolar disorder in children and adolescents: Recent progress
    Pfeifer J.C.
    Kowatch R.A.
    DelBello M.P.
    [J]. CNS Drugs, 2010, 24 (7) : 575 - 593
  • [63] Patterns of Quetiapine Use in Psychiatric Inpatients: An Examination of Off-Label Use
    Philip, Noah S.
    Mello, Kerry
    Carpenter, Linda L.
    Tyrka, Audrey R.
    Price, Lawrence H.
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2008, 20 (01) : 15 - 20
  • [64] Diagnosis of manic episodes in adolescent inpatients: structured diagnostic procedures compared to clinical chart diagnoses
    Pogge, DL
    Wayland-Smith, D
    Zaccario, M
    Borgaro, S
    Stokes, J
    Harvey, PD
    [J]. PSYCHIATRY RESEARCH, 2001, 101 (01) : 47 - 54
  • [65] Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders - Results of a 2-year extension study
    Reyes, M
    Olah, R
    Csaba, K
    Augustyns, I
    Eerdekens, M
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2006, 15 (02) : 97 - 104
  • [66] Rost K, 1994, Arch Fam Med, V3, P333, DOI 10.1001/archfami.3.4.333
  • [67] Antipsychotic Drugs for First-Episode Schizophrenia A Comparative Review
    Salimi, Kayvon
    Jarskog, L. Fredrik
    Lieberman, Jeffrey A.
    [J]. CNS DRUGS, 2009, 23 (10) : 837 - 855
  • [68] Experience of VA psychiatrists with pharmaceutical detailing of antipsychotic medications
    Sernyak, Michael
    Rosenheck, Robert
    [J]. PSYCHIATRIC SERVICES, 2007, 58 (10) : 1292 - 1296
  • [69] A TYPOLOGICAL MODEL OF SCHIZOPHRENIA BASED ON AGE AT ONSET, SEX AND FAMILIAL MORBIDITY
    SHAM, PC
    MACLEAN, CJ
    KENDLER, KS
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 (02) : 135 - 141
  • [70] Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia
    Shi, Lizheng
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas
    Montgomery, William
    Marder, Stephen R.
    [J]. PSYCHIATRIC SERVICES, 2007, 58 (04) : 482 - 488